AI-powered imaging solution from Hologic gains FDA approval
Hologic has received FDA approval of its AI-based solution designed to speed up interpretation times for digital breast tomosynthesis (DBT) exams.
The solution, 3DQuorum Imaging Technology, was developed using Hologic’s new Genius AI platform. It reconstructs 3D imaging data in a way that reduces the total number of images without impacting their quality, which Hologic says allows the radiologist to interpret exams at a faster rate.
“Superior breast cancer detection begins with our superior imaging, and only Hologic offers a comprehensive breast health ecosystem that improves outcomes, reduces costs, and increases patient and clinician satisfaction,” Pete Valenti, Hologic’s division president for breast and skeletal health solutions, said in a prepared statement. “3DQuorum technology is the first of many products to come powered by our new Genius AI technology platform, which will further revolutionize cancer detection in the coming years. 3DQuorum technology delivers meaningful productivity gains for radiologists due to a significant reduction in read time.”
3DQuorum Imaging Technology is available as part of the company’s Clarity HD Plus technology package. According to the statement, it was developed to work with both existing and brand new Hologic systems.
Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.